Findings

What do systematic reviews say?

12 questions · 12 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 7 · 58.3%Low 5 · 41.7%Moderate 0 · 0%High 0 · 0%

GnRHa treatment vs danazol

Relief of pain · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs placebo

Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis

GnRHas may leads to higher relief of overall pain ‐ reported as pelvic pain ‐ 3 months compared with placebo (low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 2.14 [1.41, 3.24]
1 study · 87 participants
Low

GnRHa treatment vs placebo

Relief of overall pain ‐ reported as dyspareunia ‐ 3 months · women with endometriosis

GnRHas may leads to higher relief of overall pain ‐ reported as dyspareunia ‐ 3 months compared with placebo (low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 2.21 [1.39, 3.54]
1 study · 87 participants
Low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as dysmenorrhoea ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs placebo

Relief of painful symptoms ‐ Dysmenorrhoea · women with endometriosis

GnRHas may leads to higher relief of overall pain ‐ reported as dysmenorrhoea ‐ 3 months compared with placebo (low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 2.25 [1.59, 3.16]
1 study · 87 participants
Low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs placebo

Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · women with endometriosis

GnRHas may leads to higher relief of overall pain ‐ reported as pelvic tenderness scores‐ 3… compared with placebo (low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 2.28 [1.48, 3.5]
1 study · 87 participants
Low

GnRHa treatment vs placebo

Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · women with endometriosis

GnRHas showed no clear difference in relief of overall pain ‐ reported as pelvic induration scores ‐ 3… compared with placebo (low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 1.07 [0.64, 1.79]
1 study · 87 participants
Low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness, partly resolved ‐ 6 months · patients with pain associated with endometriosis

It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, partly… compared with danazol (very low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 1.15 [0.49, 2.73]
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness, complete resolved ‐ 6 months · patients with pain associated with endometriosis

It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, complete… compared with danazol (very low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 1.1 [0.67, 1.81]
1 study · 41 participants
Very low